| 000 | 01413 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515061449.0 | ||
| 264 | 0 | _c20070614 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a1173-2563 | ||
| 024 | 7 |
_a10.2165/00044011-200727040-00007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRaslová, Katarina | |
| 245 | 0 | 0 |
_aInsulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index. _h[electronic resource] |
| 260 |
_bClinical drug investigation _c2007 |
||
| 300 |
_a279-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xanalogs & derivatives |
| 650 | 0 | 4 | _aInsulin Detemir |
| 650 | 0 | 4 | _aInsulin, Long-Acting |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aWeight Gain _xdrug effects |
| 700 | 1 | _aTamer, Soren Can | |
| 700 | 1 | _aClauson, Per | |
| 700 | 1 | _aKarl, Diane | |
| 773 | 0 |
_tClinical drug investigation _gvol. 27 _gno. 4 _gp. 279-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00044011-200727040-00007 _zAvailable from publisher's website |
| 999 |
_c16913952 _d16913952 |
||